FDA Announces April 26 Meeting on Int'l Cosmetics Regs
The Food and Drug Administration is announcing a public meeting on April 26, 2011 to provide information and receive comments on the International Cooperation on Cosmetics Regulations (ICCR) and the upcoming ICCR -5 meeting in Paris, France.
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
(ICCR is a voluntary, international group of cosmetics regulatory authorities from the U.S., Japan, the European Union, and Canada. The purpose of the multilateral framework on the ICCR is to pave the way for the removal of regulatory obstacles to international trade while maintaining global consumer protection.)
Meeting to Discuss ICCR, Upcoming Paris Meetings
The topics to be discussed at the meeting will focus on issues on the agenda for the forthcoming ICCR Steering Committee meeting. The purpose of the meeting is to solicit public input prior to the next steering committee and expert working group meetings in Paris, France scheduled on June 28 through July 1, 2011.
FDA Meeting Schedule Posted on its Website
The schedule for FDA's April 26th meeting has been posted to its website. Areas to be covered include an introduction and overview of the ICCR process; an overview of Center for Food Safety and Applied Nutrition (CFSAN) ICCR issues; an overview of Center for Drug Evaluation and Research (CDER) ICCR issues/sunscreen issues; and an overview of industry, NGO, and public comments.
Outcomes of 2010 ICCR-4 Meeting
The following are outcomes from the ICCR-4 meeting, held in July 2010:
Alternative Test Methods. Regulators received an updated report on International Cooperation on Alternative Test Methods activities. Regulatory authorities will continue to cooperate, to coordinate and to endorse International Cooperation on Alternative Test Methods (ICATM) activities.
Cosmetics Labeling. Industry working group identified three areas of labeling misalignment: small packaging, declaration of net quantity of contents, net content and warnings on aerosol products. ICCR regulators decided not to form a labeling ICCR WG.
Involvement of Interested Parties in ICCR. Regulators will develop criteria to allow interested parties to submit detailed proposals for work items for ICCR members’ consideration. Regulators reviewed criteria for new regulatory membership to finalize for future adoption.
Nanotechnology. Regulators and industry discussed the report of the ICCR Ad Hoc Nanotechnology Working Group that was formed in December 2009 to develop criteria for identification of nanomaterials within the context of cosmetic regulation. This Nano WG has concluded its work with the finalization of the report. A new Nano WG will be formed to examine safety approaches.
Standard Operating Procedures of Working Groups. Regulators developed a draft Standard Operating Procedure for Working Groups under the ICCR framework, for adoption in the near future.
Sunscreens. Regulators shared information on approaches to sunscreen regulation.
Trace Contaminants. ICCR Ad Hoc Traces Working Group provided a status update on the development of a trace materials framework document and recommendations for maximum lead contamination levels. Work will continue on the framework document and on recommendations for three trace contaminants (lead, 1,4-dioxane and mercury).
The agenda for the public meeting is available here.
FDA Contact -- Kimberly Franklin Kimberly.Franklin@fda.hhs.gov
(DN FDA-2011-N-0002, FR Pub 03/05/11)